Cargando…
Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
PURPOSE: To determine the characteristics of diabetic macular edema (DME) patients refractory to intravitreal bevacizumab (IVB) treatments and an additional dexamethasone implant. METHODS: We classified 119 DME patients according to whether or not they are responsive to 3 consecutive monthly anti-VE...
Autores principales: | Choi, Moon Young, Jee, Donghyun, Kwon, Jin-woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742354/ https://www.ncbi.nlm.nih.gov/pubmed/31513661 http://dx.doi.org/10.1371/journal.pone.0222364 |
Ejemplares similares
-
Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
por: Kwon, Jin-woo, et al.
Publicado: (2018) -
Correction: Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
por: Kwon, Jin-woo, et al.
Publicado: (2018) -
Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
por: Nalçacı, Serhad, et al.
Publicado: (2019) -
Risk factors for ocular hypertension after intravitreal dexamethasone implantation in diabetic macular edema
por: Choi, Moon Young, et al.
Publicado: (2020) -
Factors associated with the duration of action of dexamethasone intravitreal implants in diabetic macular edema patients
por: Park, Young Gun, et al.
Publicado: (2019)